Drug Profile
POT II
Latest Information Update: 07 Jul 1999
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antihyperglycaemics
- Mechanism of Action Chymotrypsin inhibitors; Leucocyte elastase inhibitors; Trypsin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Type 2 diabetes mellitus
Most Recent Events
- 07 Jul 1999 Profile reviewed
- 07 Jul 1999 No-Development-Reported for Type-2 diabetes mellitus in USA (PO)
- 08 Apr 1997 New profile